SuperSaturated Oxygen Comprehensive Observational Registry
TherOx
Summary
The SuperSaturated Oxygen Comprehensive Observational Registry (SSCORE) registry, a prospectively designed observational study, aims to evaluate the clinical utility and effectiveness of SuperSaturated Oxygen (SSO2) Therapy versus percutaneous coronary intervention (PCI) alone among patients with anterior acute myocardial infarction (AMI) in routine clinical practice. The goal is to collect real-world data from patients treated with SSO2 Therapy to determine its impact on the overall heart failure (HF) burden on patients and healthcare systems compared with usual care for treatment of patients with AMI. The SSCORE Registry will generate effectiveness and healthcare resource utilization data that will be used in cost-effectiveness analysis modeling.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria Subjects screened for either the Prospective Control Cohort or the SSO2 Treated (On-Label or All Others) Cohorts must meet ALL the following baseline criteria: * Men or women aged 18 years or older * Presentation with AMI and successful revascularization of the infarct-related artery with PCI * The subject or their legally authorized representative has been informed of the nature of the study, agrees to its provisions and has been provided and signed written informed consent, approved by the appropriate Institutional Review Board (IRB) Treatment with SSO2 Therapy will be…
Interventions
- OtherNo intervention
No intervention
Locations (24)
- MemorialCare Orange Coast Medical CenterFountain Valley, California
- UCSD Health La Jolla - Sulpizio Cardiovascular CenterLa Jolla, California
- MemorialCare Saddleback Medical CenterLaguna Hills, California
- MemorialCare Long Beach Medical CenterLong Beach, California
- Ronald Reagan UCLA Medical CenterLos Angeles, California
- UCSD Hillcrest Medical CenterSan Diego, California